Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 1-butylamine
2. N-butylamine
3. N-butylamine Hydrobromide
4. N-butylamine Hydrochloride
5. N-butylamine Hydrochloride, 14c-labeled Cpd
1. Butan-1-amine
2. N-butylamine
3. 109-73-9
4. 1-butanamine
5. 1-aminobutane
6. 1-butylamine
7. Monobutylamine
8. N-butylamin
9. Norvalamine
10. Mono-n-butylamine
11. 1-aminobutan
12. 1-amino-butaan
13. Monobutilamina
14. Butanamine
15. Butyl Amine
16. N-butilamina
17. N-butyl Amine
18. Fema No. 3130
19. Norralamine
20. Nsc 8029
21. Mfcd00011690
22. N-c4h9nh2
23. N2qv60b4wr
24. Chebi:43799
25. Nsc-8029
26. N-butylamin [german]
27. N-butilamina [italian]
28. 1-aminobutan [german]
29. Fema Number 3130
30. Monobutilamina [romanian]
31. 1-amino-butaan [dutch]
32. Butylamine, N-
33. Ccris 4756
34. Hsdb 515
35. Einecs 203-699-2
36. Un1125
37. Unii-n2qv60b4wr
38. Aminobutane
39. Butylarnine
40. N-butyiamine
41. Ai3-24197
42. N-butyl-amine
43. Butane-1-amine
44. N-butan-1-amine
45. Normal-butyl Amine
46. N-butylamine Nba
47. Butylamine, 99%
48. Nbunh2
49. 1-butanamine, 9ci
50. Bunh2
51. Aminobutane (related)
52. N-bunh2
53. Butylamine, N
54. Butylamine, >=99%
55. Butylamine, 99.5%
56. 1-amino-butane
57. 1-butanaminen-butilamina
58. Butylamine [fhfi]
59. Dsstox_cid_1904
60. N-butylamine [mi]
61. Ec 203-699-2
62. Butylamine [mart.]
63. Dsstox_rid_76395
64. N-butylamine [hsdb]
65. Nciopen2_009229
66. Dsstox_gsid_21904
67. Wln: Z4
68. Chembl13968
69. Butylamine, Puriss., 99.0%
70. Dtxsid1021904
71. Fema 3130
72. Nsc8029
73. Amy21914
74. Str01992
75. Zinc1586365
76. Tox21_301131
77. Bbl027788
78. Stl308736
79. Akos000118810
80. Butylamine, Purum, >=98.0% (gc)
81. Butylamine, Purum, >=99.0% (gc)
82. Db03659
83. Un 1125
84. Butylamine, Analytical Reference Material
85. Butylamine, Puriss., >=99.5% (gc)
86. Ncgc00248302-01
87. Ncgc00255030-01
88. Bp-30251
89. Cas-109-73-9
90. Lyt
91. B0707
92. Ft-0623326
93. N-butylamine [un1125] [flammable Liquid]
94. Q421035
95. J-002322
96. F2190-0358
| Molecular Weight | 73.14 g/mol |
|---|---|
| Molecular Formula | C4H11N |
| XLogP3 | 1 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 1 |
| Rotatable Bond Count | 2 |
| Exact Mass | 73.089149355 g/mol |
| Monoisotopic Mass | 73.089149355 g/mol |
| Topological Polar Surface Area | 26 Ų |
| Heavy Atom Count | 5 |
| Formal Charge | 0 |
| Complexity | 13.1 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
... Recovered little ... n-butylamine in the urine after oral administration of the hydrochloride of this compound to humans ...
Clayton, G. D. and F. E. Clayton (eds.). Patty's Industrial Hygiene and Toxicology: Volume 2A, 2B, 2C: Toxicology. 3rd ed. New York: John Wiley Sons, 1981-1982., p. 3141
Amines are well absorbed from gut & respiratory tract. /Aliphatic amines/
Bingham, E.; Cohrssen, B.; Powell, C.H.; Patty's Toxicology Volumes 1-9 5th ed. John Wiley & Sons. New York, N.Y. (2001)., p. 4:690
Monoamine oxidase and diamine oxidase (histaminase) occur widely in animal tissues ... it is assumed that they play an important part in "detoxication" of amines not normally present /in the body/. /Aliphatic amines/
Clayton, G. D. and F. E. Clayton (eds.). Patty's Industrial Hygiene and Toxicology: Volume 2A, 2B, 2C: Toxicology. 3rd ed. New York: John Wiley Sons, 1981-1982., p. 3141
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A N-Butylamine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of N-Butylamine, including repackagers and relabelers. The FDA regulates N-Butylamine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. N-Butylamine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A N-Butylamine supplier is an individual or a company that provides N-Butylamine active pharmaceutical ingredient (API) or N-Butylamine finished formulations upon request. The N-Butylamine suppliers may include N-Butylamine API manufacturers, exporters, distributors and traders.
N-Butylamine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of N-Butylamine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right N-Butylamine GMP manufacturer or N-Butylamine GMP API supplier for your needs.
A N-Butylamine CoA (Certificate of Analysis) is a formal document that attests to N-Butylamine's compliance with N-Butylamine specifications and serves as a tool for batch-level quality control.
N-Butylamine CoA mostly includes findings from lab analyses of a specific batch. For each N-Butylamine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
N-Butylamine may be tested according to a variety of international standards, such as European Pharmacopoeia (N-Butylamine EP), N-Butylamine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (N-Butylamine USP).
LOOKING FOR A SUPPLIER?
